scispace - formally typeset
A

Andreas Humm

Researcher at Max Planck Society

Publications -  14
Citations -  699

Andreas Humm is an academic researcher from Max Planck Society. The author has contributed to research in topics: Arginine:glycine amidinotransferase & Cofactor. The author has an hindex of 11, co-authored 11 publications receiving 668 citations. Previous affiliations of Andreas Humm include Hoffmann-La Roche.

Papers
More filters
Journal ArticleDOI

Crystal structure of the first dissimilatory nitrate reductase at 1.9 A solved by MAD methods.

TL;DR: The polypeptide fold of NAP and the arrangement of the cofactors is related to that of Escherichia coli formate dehydrogenase (FDH) and distantly resembles dimethylsulphoxide reductase.
Journal ArticleDOI

Bioincorporation of telluromethionine into proteins: a promising new approach for X-ray structure analysis of proteins

TL;DR: The production of telluromethionine-proteins as heavy-atom derivatives offers a valid and general approach in X-ray analysis by the method of multiple isomorphous replacement.
Journal ArticleDOI

Crystal structure and mechanism of human l-arginine: glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis

TL;DR: The crystal structure of the recombinant human enzyme by multiple isomorphous replacement at 1.9 Å resolution is determined and a reaction mechanism with a catalytic triad Cys–His–Asp is proposed on the basis of substrate and product bound states.
Journal ArticleDOI

Crystal structure of L-arginine : inosamine-phosphate amidinotransferase StrB1 from Streptomyces griseus : an enzyme involved in streptomycin biosynthesis

TL;DR: Molecular modeling revealed a possible binding mode for the second substrate scyllo-inosamine 4-phosphate and the residues which are involved in substrate binding and catalysis are conserved in AT and StrB1 and are at equivalent topological positions, suggesting a similar reaction mechanism among amidinotransferases.
Journal ArticleDOI

Recombinant expression and isolation of human l-arginine:glycine amidinotransferase and identification of its active-site cysteine residue

TL;DR: A new method for the removal of N-terminal fusion peptides by means of an immobilized snake venom prothrombin activator is established and cysteine-407 is identified as the active-site residue of AT by radioactive labelling and isolation of labelled peptides, and by site-directed mutagenesis of the protein.